A groundbreaking clinical trial presented at the American Society for Clinical Oncology (ASCO) conference in Chicago has revealed that a pill called osimertinib, marketed as Tagrisso, can significantly reduce the risk of death from a specific type of lung cancer. The trial involved over 680 participants who had undergone surgery to remove the tumor and those who were at an early stage of the disease. Results showed that patients who took osimertinib daily experienced a 51% reduction in the risk of death compared to those who took a placebo. The drug also helps prevent the spread of cancer to other organs. Osimertinib has already been authorized for various indications in multiple countries and has been given to around 700,000 individuals. However, it is crucial to screen patients for the specific mutation targeted by the drug before administering treatment. Side effects of osimertinib include severe fatigue, skin rashes, and diarrhea.
Related Posts
Recent Research Reveals Balanced Approach to Cardiovascular Health
New research conducted at Iowa State University reveals that allocating the recommended physical activity between aerobic and resistance exercise equally can substantially reduce the risks of cardiovascular disease, equivalent to regimens solely focused on aerobic exercise. Cardiovascular disease contributes to one in three deaths in the United States, emphasizing the significance of preventive measures. The […]
Tiny Titans: Scientists Create Mini Cells That Talk to Each Other
Move over walkie-talkies, the future of communication is microscopic! Scientists have just achieved a groundbreaking feat: creating synthetic mini-cells that can send and receive protein and RNA messages to each other. This breakthrough not only deepens our understanding of how cells function but also opens doors to revolutionary advancements in medicine, biomaterials, and even artificial […]
Biomass adenosine triphosphate filler for improving the fire resistance and smoke suppression of intumescent coatings
Intumescent coatings are a crucial fire safety technology, forming a protective barrier that expands and insulates underlying materials when exposed to high temperatures. Traditionally, these coatings rely on halogenated or phosphorus-based flame retardants, raising concerns about environmental toxicity and human health. However, recent research has explored biomass adenosine triphosphate (ATP) as a promising green alternative […]